The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases

Overview of attention for article published in BMC Infectious Diseases, August 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (63rd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 53 Dimensions

Readers on

mendeley: 89 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 12,180 followers.

@IdVilchez @JMRocco5 @DDHVillanueva @MelinhL @id_cure @DocWoc71 @AlexandreMALEK @davidvanduin @wfwrighID @DrToddLee https://t.co/FVZ5XYWGzo

09 Jul 2021

Reply Repost Favourite

RT @SAIRABT: #inhaled #amikacin for #MAC #NTM https://t.co/drFXHwNSQO https://t.co/qQLArU7UJE

29 Sep 2018

Reply Repost Favourite

#inhaled #amikacin for #MAC #NTM https://t.co/drFXHwNSQO

28 Sep 2018

Reply Repost Favourite

The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases https://t.co/I86vijI5uH

18 Feb 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.